Paul Neff
Director/Board Member at ACRES COMMERCIAL REALTY CORP.
Net worth: 347 661 $ as of 2024-04-29
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Steven Kessler | M | 81 | 19 years | |
| Bradley Campbell | M | 48 | 18 years | |
| David Bryant | M | 66 | 18 years | |
| Dawanna Williams | F | 55 | 3 years | |
| Eldron Blackwell | M | 44 | 10 years | |
| Peter Schneider | M | - |
Intact Vascular, Inc.
 Intact Vascular, Inc. Medical SpecialtiesHealth Technology Intact Vascular, Inc. develops products for minimally invasive peripheral vascular procedures. Its tack endovascular system is designed to optimize peripheral balloon angioplasty results in the treatment of peripheral artery disease and this technology will offer physicians a new treatment option for treating peripheral artery disease. The company was founded by Robert Mero Giasolli and Peter M. Schneider in 2011 and is headquartered in Wayne, PA. | 13 years |
| Mike Raab Raab | M | 59 | 20 years | |
| Mark Fogel | M | 55 | 4 years | |
| James McEntee | M | 66 | 24 years | |
| Ira Mark Lubert | M | 73 |
Quaker Partners Management LP
 Quaker Partners Management LP Investment ManagersFinance Quaker Partners Management LP (Quaker Partners Mgmt) is a venture capital subsidiary of Independence Capital Partners Inc founded in 2002 by Ira Mark Lubert and Paul Sherrill Neff. The firm is headquartered in Philadelphia, Pennsylvania. | 22 years |
| Glenn Sblendorio | M | 68 | 18 years | |
| Jaclyn Jesberger | F | 46 | 4 years | |
| Brian Schwenk | M | - |
Quaker Partners Management LP
Quaker Partners Management LP Investment ManagersFinance Quaker Partners Management LP (Quaker Partners Mgmt) is a venture capital subsidiary of Independence Capital Partners Inc founded in 2002 by Ira Mark Lubert and Paul Sherrill Neff. The firm is headquartered in Philadelphia, Pennsylvania. | 12 years |
| Andrew Fentress | M | 54 | 4 years | |
| Gary Ickowicz | M | 68 | 17 years | |
| Linda Kilpatrick | F | 51 | 14 years | |
| Margaret McGlynn | F | 64 | 15 years | |
| Karen Edwards | F | 67 | 3 years | |
| Murray Levin | M | 81 | 19 years | |
| Norman Schwartz | M | 74 |
RainDance Technologies, Inc.
 RainDance Technologies, Inc. Medical SpecialtiesHealth Technology RainDance Technologies, Inc. engages in the development and commercialization of professional laboratory system. It develops and manufactures genomic tools for non-invasive liquid biopsy applications for the research, early detection, treatment of cancer, and inherited and infectious diseases. The company was founded by Andrew Griffiths, Darren R. Link, and Jerome Bibette in 2004 and is headquartered in Billerica, MA. | - |
| William Hart | M | 80 | 19 years | |
| Matthew Cohn | M | 54 | 25 years | |
| Terry McGuire | M | 68 |
National Venture Capital Association
 National Venture Capital Association Miscellaneous Commercial ServicesCommercial Services National Venture Capital Association provides business association services. It facilitates networking opportunities and provides research data to its members. The company is headquartered in Washington, DC. | 15 years |
| Douglas Evans | M | 59 |
Intact Vascular, Inc.
Intact Vascular, Inc. Medical SpecialtiesHealth Technology Intact Vascular, Inc. develops products for minimally invasive peripheral vascular procedures. Its tack endovascular system is designed to optimize peripheral balloon angioplasty results in the treatment of peripheral artery disease and this technology will offer physicians a new treatment option for treating peripheral artery disease. The company was founded by Robert Mero Giasolli and Peter M. Schneider in 2011 and is headquartered in Wayne, PA. | 8 years |
| Bruce Robertson | M | 61 |
Intact Vascular, Inc.
Intact Vascular, Inc. Medical SpecialtiesHealth Technology Intact Vascular, Inc. develops products for minimally invasive peripheral vascular procedures. Its tack endovascular system is designed to optimize peripheral balloon angioplasty results in the treatment of peripheral artery disease and this technology will offer physicians a new treatment option for treating peripheral artery disease. The company was founded by Robert Mero Giasolli and Peter M. Schneider in 2011 and is headquartered in Wayne, PA. | - |
| Jennifer Tweet | F | - |
RainDance Technologies, Inc.
RainDance Technologies, Inc. Medical SpecialtiesHealth Technology RainDance Technologies, Inc. engages in the development and commercialization of professional laboratory system. It develops and manufactures genomic tools for non-invasive liquid biopsy applications for the research, early detection, treatment of cancer, and inherited and infectious diseases. The company was founded by Andrew Griffiths, Darren R. Link, and Jerome Bibette in 2004 and is headquartered in Billerica, MA. | - |
| Kyle Brengel | M | 33 | 4 years | |
| Mike Longo | M | - |
Intact Vascular, Inc.
Intact Vascular, Inc. Medical SpecialtiesHealth Technology Intact Vascular, Inc. develops products for minimally invasive peripheral vascular procedures. Its tack endovascular system is designed to optimize peripheral balloon angioplasty results in the treatment of peripheral artery disease and this technology will offer physicians a new treatment option for treating peripheral artery disease. The company was founded by Robert Mero Giasolli and Peter M. Schneider in 2011 and is headquartered in Wayne, PA. | 11 years |
| Monica L. Klos | F | - |
Intact Vascular, Inc.
Intact Vascular, Inc. Medical SpecialtiesHealth Technology Intact Vascular, Inc. develops products for minimally invasive peripheral vascular procedures. Its tack endovascular system is designed to optimize peripheral balloon angioplasty results in the treatment of peripheral artery disease and this technology will offer physicians a new treatment option for treating peripheral artery disease. The company was founded by Robert Mero Giasolli and Peter M. Schneider in 2011 and is headquartered in Wayne, PA. | - |
| Marc Penna | M | - |
Intact Vascular, Inc.
Intact Vascular, Inc. Medical SpecialtiesHealth Technology Intact Vascular, Inc. develops products for minimally invasive peripheral vascular procedures. Its tack endovascular system is designed to optimize peripheral balloon angioplasty results in the treatment of peripheral artery disease and this technology will offer physicians a new treatment option for treating peripheral artery disease. The company was founded by Robert Mero Giasolli and Peter M. Schneider in 2011 and is headquartered in Wayne, PA. | 9 years |
| Jeffrey Castelli | M | - | 19 years | |
| Timothy Ernst | M | 64 |
RainDance Technologies, Inc.
RainDance Technologies, Inc. Medical SpecialtiesHealth Technology RainDance Technologies, Inc. engages in the development and commercialization of professional laboratory system. It develops and manufactures genomic tools for non-invasive liquid biopsy applications for the research, early detection, treatment of cancer, and inherited and infectious diseases. The company was founded by Andrew Griffiths, Darren R. Link, and Jerome Bibette in 2004 and is headquartered in Billerica, MA. | - |
| Peter Klein | M | 46 |
Intact Vascular, Inc.
Intact Vascular, Inc. Medical SpecialtiesHealth Technology Intact Vascular, Inc. develops products for minimally invasive peripheral vascular procedures. Its tack endovascular system is designed to optimize peripheral balloon angioplasty results in the treatment of peripheral artery disease and this technology will offer physicians a new treatment option for treating peripheral artery disease. The company was founded by Robert Mero Giasolli and Peter M. Schneider in 2011 and is headquartered in Wayne, PA. | - |
| Richard J. Busis | M | - |
Greater Philadelphia Venture Group
| - |
| Roch W. Kelly | M | - |
RainDance Technologies, Inc.
RainDance Technologies, Inc. Medical SpecialtiesHealth Technology RainDance Technologies, Inc. engages in the development and commercialization of professional laboratory system. It develops and manufactures genomic tools for non-invasive liquid biopsy applications for the research, early detection, treatment of cancer, and inherited and infectious diseases. The company was founded by Andrew Griffiths, Darren R. Link, and Jerome Bibette in 2004 and is headquartered in Billerica, MA. | 16 years |
| Michael Hunkapiller | M | 75 |
RainDance Technologies, Inc.
RainDance Technologies, Inc. Medical SpecialtiesHealth Technology RainDance Technologies, Inc. engages in the development and commercialization of professional laboratory system. It develops and manufactures genomic tools for non-invasive liquid biopsy applications for the research, early detection, treatment of cancer, and inherited and infectious diseases. The company was founded by Andrew Griffiths, Darren R. Link, and Jerome Bibette in 2004 and is headquartered in Billerica, MA. | 17 years |
| Ronald W. Hutton | M | 66 |
RainDance Technologies, Inc.
RainDance Technologies, Inc. Medical SpecialtiesHealth Technology RainDance Technologies, Inc. engages in the development and commercialization of professional laboratory system. It develops and manufactures genomic tools for non-invasive liquid biopsy applications for the research, early detection, treatment of cancer, and inherited and infectious diseases. The company was founded by Andrew Griffiths, Darren R. Link, and Jerome Bibette in 2004 and is headquartered in Billerica, MA. | - |
| Adele Oliva | F | 58 |
Quaker Partners Management LP
Quaker Partners Management LP Investment ManagersFinance Quaker Partners Management LP (Quaker Partners Mgmt) is a venture capital subsidiary of Independence Capital Partners Inc founded in 2002 by Ira Mark Lubert and Paul Sherrill Neff. The firm is headquartered in Philadelphia, Pennsylvania. | 17 years |
| Jeffrey D. Samberg | M | - |
RainDance Technologies, Inc.
RainDance Technologies, Inc. Medical SpecialtiesHealth Technology RainDance Technologies, Inc. engages in the development and commercialization of professional laboratory system. It develops and manufactures genomic tools for non-invasive liquid biopsy applications for the research, early detection, treatment of cancer, and inherited and infectious diseases. The company was founded by Andrew Griffiths, Darren R. Link, and Jerome Bibette in 2004 and is headquartered in Billerica, MA. | 17 years |
| Dennis Wahr | M | - |
Intact Vascular, Inc.
Intact Vascular, Inc. Medical SpecialtiesHealth Technology Intact Vascular, Inc. develops products for minimally invasive peripheral vascular procedures. Its tack endovascular system is designed to optimize peripheral balloon angioplasty results in the treatment of peripheral artery disease and this technology will offer physicians a new treatment option for treating peripheral artery disease. The company was founded by Robert Mero Giasolli and Peter M. Schneider in 2011 and is headquartered in Wayne, PA. | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Thomas C. Elliott | M | 51 | 16 years | |
| Jonathan Cohen | M | 53 | 18 years | |
| Walter Thomas Beach | M | 57 | 22 years | |
| Daphne Quimi | F | 58 | 18 years | |
| Frank M. Mastrangelo | M | 56 | 16 years | |
| Prabhavathi Fernandes | M | 74 |
Cempra Pharmaceuticals, Inc.
 Cempra Pharmaceuticals, Inc. BiotechnologyHealth Technology Cempra Pharmaceuticals, Inc. develops medicines for treating drug-resistant bacterial infections. The firm's antibacterial products, both in clinical trials, address the urgent and increasing need for new treatments targeting drug-resistant bacterial infections in both the hospital and the community. The company was founded by Prabhavathi B. Fernandes IN 2006 and is headquartered in Chapel Hill, NC. | 11 years |
| Michael S. Yecies | M | 56 | - | |
| Marlene Krauss | M | 79 | 4 years | |
| John Crowley | M | 57 | 22 years | |
| Betsy Cohen | F | 82 | 15 years | |
| Matt Rieke | M | - |
Quaker Partners Management LP
Quaker Partners Management LP Investment ManagersFinance Quaker Partners Management LP (Quaker Partners Mgmt) is a venture capital subsidiary of Independence Capital Partners Inc founded in 2002 by Ira Mark Lubert and Paul Sherrill Neff. The firm is headquartered in Philadelphia, Pennsylvania. | - |
| John M. McAdam | M | 49 | 4 years | |
| Sirshendu Roopom Banerjee | M | 48 |
RainDance Technologies, Inc.
RainDance Technologies, Inc. Medical SpecialtiesHealth Technology RainDance Technologies, Inc. engages in the development and commercialization of professional laboratory system. It develops and manufactures genomic tools for non-invasive liquid biopsy applications for the research, early detection, treatment of cancer, and inherited and infectious diseases. The company was founded by Andrew Griffiths, Darren R. Link, and Jerome Bibette in 2004 and is headquartered in Billerica, MA. | 6 years |
| Bruce Shook | M | 65 |
Intact Vascular, Inc.
Intact Vascular, Inc. Medical SpecialtiesHealth Technology Intact Vascular, Inc. develops products for minimally invasive peripheral vascular procedures. Its tack endovascular system is designed to optimize peripheral balloon angioplasty results in the treatment of peripheral artery disease and this technology will offer physicians a new treatment option for treating peripheral artery disease. The company was founded by Robert Mero Giasolli and Peter M. Schneider in 2011 and is headquartered in Wayne, PA. | 6 years |
| Christopher A. Thatcher | M | 59 | 6 years | |
| Brian E. Farley | M | 66 | 12 years | |
| Donald Hayden | M | 68 | 12 years | |
| Drew Marcus | M | - |
Alex. Brown & Sons, Inc.
| 13 years |
| Mayo Shattuck | M | 69 |
Alex. Brown & Sons, Inc.
| 6 years |
| Edward Cohen | M | 85 | 16 years | |
| Sol Barer | M | 76 | 8 years | |
| Andy Watson | M | - |
RainDance Technologies, Inc.
RainDance Technologies, Inc. Medical SpecialtiesHealth Technology RainDance Technologies, Inc. engages in the development and commercialization of professional laboratory system. It develops and manufactures genomic tools for non-invasive liquid biopsy applications for the research, early detection, treatment of cancer, and inherited and infectious diseases. The company was founded by Andrew Griffiths, Darren R. Link, and Jerome Bibette in 2004 and is headquartered in Billerica, MA. | 3 years |
| George Hornig | M | 69 | 3 years | |
| Pamela Schreiber | F | - | - | |
| Douglas A. Branch | M | - | - | |
| Stephen M. Campe | M | 59 | 7 years | |
| Geeta S. Vemuri | M | - |
Quaker Partners Management LP
Quaker Partners Management LP Investment ManagersFinance Quaker Partners Management LP (Quaker Partners Mgmt) is a venture capital subsidiary of Independence Capital Partners Inc founded in 2002 by Ira Mark Lubert and Paul Sherrill Neff. The firm is headquartered in Philadelphia, Pennsylvania. | - |
| Purvi Kamdar | F | - | - | |
| Darren R. Link | M | - |
RainDance Technologies, Inc.
RainDance Technologies, Inc. Medical SpecialtiesHealth Technology RainDance Technologies, Inc. engages in the development and commercialization of professional laboratory system. It develops and manufactures genomic tools for non-invasive liquid biopsy applications for the research, early detection, treatment of cancer, and inherited and infectious diseases. The company was founded by Andrew Griffiths, Darren R. Link, and Jerome Bibette in 2004 and is headquartered in Billerica, MA. | 13 years |
| Steven R. Saltzman | M | 60 | 16 years | |
| Herb A. May | M | - |
Alex. Brown & Sons, Inc.
| 13 years |
| S. Schaeffer | F | 55 | 7 years | |
| Michele Weisbaum | F | 62 | - | |
| Robert Lieber | M | 69 | 4 years | |
| Michael Bradley | M | 79 | 11 years | |
| Dennis Langer | M | 73 |
Neose Technologies, Inc.
 Neose Technologies, Inc. Pharmaceuticals: MajorHealth Technology The Group's principal activity is to develop proprietary drugs, focusing primarily on therapeutic proteins. Its technologies to develop proprietary versions of protein drugs with proven safety and efficacy and to improve the therapeutic profiles of proteins being developed. Its proprietary drug development portfolio currently consists of two therapeutic protein candidates.GlycoPEG-EPO (NE-180) is a long-acting version of erythropoietin (EPO) produced in insect cells. EPO is prescribed to stimulate production of red blood cells, and it gives treatment of chemotherapy-induced anemia and anemia associated with chronic renal failure. Its second proprietary protein, GlycoPEG-GCSF, is a long-acting version of granulocyte colony stimulating factor G-CSF and it is prescribed to stimulate production of neutrophils (a type of white blood cell). Its trademarks are NEOSE, GlycoPEGylation and GlycoConjugation. It operates predominantly in the domestic market. | 3 years |
| Mohan Ganesan | M | 56 | 4 years | |
| Debra J. Poul | F | 71 |
Neose Technologies, Inc.
Neose Technologies, Inc. Pharmaceuticals: MajorHealth Technology The Group's principal activity is to develop proprietary drugs, focusing primarily on therapeutic proteins. Its technologies to develop proprietary versions of protein drugs with proven safety and efficacy and to improve the therapeutic profiles of proteins being developed. Its proprietary drug development portfolio currently consists of two therapeutic protein candidates.GlycoPEG-EPO (NE-180) is a long-acting version of erythropoietin (EPO) produced in insect cells. EPO is prescribed to stimulate production of red blood cells, and it gives treatment of chemotherapy-induced anemia and anemia associated with chronic renal failure. Its second proprietary protein, GlycoPEG-GCSF, is a long-acting version of granulocyte colony stimulating factor G-CSF and it is prescribed to stimulate production of neutrophils (a type of white blood cell). Its trademarks are NEOSE, GlycoPEGylation and GlycoConjugation. It operates predominantly in the domestic market. | 10 years |
| Michael Barrett | M | 81 | 6 years | |
| David Palling | M | 70 | - | |
| E. Roger Novak | M | 75 |
National Venture Capital Association
National Venture Capital Association Miscellaneous Commercial ServicesCommercial Services National Venture Capital Association provides business association services. It facilitates networking opportunities and provides research data to its members. The company is headquartered in Washington, DC. | 3 years |
| Joseph A. Williamson | M | 71 | 3 years | |
| Nancy J. McGurk | F | 68 | 15 years | |
| Frank Baldino | M | 71 |
Quaker Partners Management LP
Quaker Partners Management LP Investment ManagersFinance Quaker Partners Management LP (Quaker Partners Mgmt) is a venture capital subsidiary of Independence Capital Partners Inc founded in 2002 by Ira Mark Lubert and Paul Sherrill Neff. The firm is headquartered in Philadelphia, Pennsylvania. | - |
| Jack Lasersohn | M | 70 |
National Venture Capital Association
National Venture Capital Association Miscellaneous Commercial ServicesCommercial Services National Venture Capital Association provides business association services. It facilitates networking opportunities and provides research data to its members. The company is headquartered in Washington, DC. | - |
| Stephanie Haynie Wiggins | F | 57 | 6 years | |
| Alexander E. Barkas | M | 76 | - | |
| C. Boyd Clarke | M | 74 |
Neose Technologies, Inc.
Neose Technologies, Inc. Pharmaceuticals: MajorHealth Technology The Group's principal activity is to develop proprietary drugs, focusing primarily on therapeutic proteins. Its technologies to develop proprietary versions of protein drugs with proven safety and efficacy and to improve the therapeutic profiles of proteins being developed. Its proprietary drug development portfolio currently consists of two therapeutic protein candidates.GlycoPEG-EPO (NE-180) is a long-acting version of erythropoietin (EPO) produced in insect cells. EPO is prescribed to stimulate production of red blood cells, and it gives treatment of chemotherapy-induced anemia and anemia associated with chronic renal failure. Its second proprietary protein, GlycoPEG-GCSF, is a long-acting version of granulocyte colony stimulating factor G-CSF and it is prescribed to stimulate production of neutrophils (a type of white blood cell). Its trademarks are NEOSE, GlycoPEGylation and GlycoConjugation. It operates predominantly in the domestic market. | 5 years |
| Samuel B. Fortenbaugh | M | 89 |
Morgan, Lewis & Bockius LLP
 Morgan, Lewis & Bockius LLP Miscellaneous Commercial ServicesCommercial Services Morgan, Lewis & Bockius LLP provides legal consulting services. It specializes in transactional, litigation, labor and employment, regulatory, and intellectual property legal services to various industries. The company was founded in 1873 and is headquartered in Philadelphia, PA. | - |
| David Edward Bloom | M | 59 | 5 years | |
| Kenneth A. Kind | M | 70 | 8 years | |
| Henry Silverman | M | 83 | 3 years | |
| Ron Hunt | M | 59 | 4 years | |
| James Topper | M | 62 | 11 years | |
| Jim Woody | M | 81 | - | |
| Geoffrey Gilmore | M | 58 | 4 years | |
| Linda Schaeffer | F | 60 | 14 years | |
| Joan Specter | F | 90 | 13 years | |
| Kathy Ordoñez | F | 73 |
RainDance Technologies, Inc.
RainDance Technologies, Inc. Medical SpecialtiesHealth Technology RainDance Technologies, Inc. engages in the development and commercialization of professional laboratory system. It develops and manufactures genomic tools for non-invasive liquid biopsy applications for the research, early detection, treatment of cancer, and inherited and infectious diseases. The company was founded by Andrew Griffiths, Darren R. Link, and Jerome Bibette in 2004 and is headquartered in Billerica, MA. | 3 years |
| Shelle Weisbaum | F | 63 | 4 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 100 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Paul Neff
- Personal Network
